tirzepatide surpass-5 reduces albuminuria among adults with type 2 diabetes in SURPASS trials SURPASS to SURMOUNT: The Tirzepatide

Mastering injection technique eliminates the most preventable cause of injection site reactions

Both are indicated to treat type 2 diabetes

Importantly, tirzepatide carries a boxed warning for thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

If you are considering Tirzepatide as part of your care plan, there are several important factors to keep in mind to ensure both safety and success

And tools without plans tend to stop working

Glycemic Control : It lowers blood sugar levels by facilitating insulin secretion and decreasing glucose production in the liver